BioSpace News Archive

Pharm Country

Axsome Therapeutics to Present at Upcoming Investor Conferences - Sep 03, 2020

Axsome Therapeutics, Inc., a biopharmaceutical company developing novel therapies for the management of central nervous system disorders, will participate in two upcoming investor conferences:

September 3, 2020
·
4 min read
BioMidwest

ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutralizing Antibodies in Plasma

ImmunoRank Offers a Faster, Simpler, More Cost Effective Way to Identify High Titer Convalescent Plasma for Use in Both Treating COVID-19 Patients and for Creating COVID-19 Hyperimmune Globulins

September 3, 2020
·
6 min read
Bio NC

RedHill Biopharma’s Opaganib Awarded COVID-19 Grant by State of Pennsylvania

A global Phase 2/3 study in up to 270 patients hospitalized with severe COVID-19 pneumonia, and a U.S. Phase 2 study in up to 40 patients, are ongoing with opaganib, a novel, orally-administered, sphingosine kinase-2 (SK2) selective inhibitor with dual anti-inflammatory and anti-viral properties

September 3, 2020
·
11 min read
Genetown

Late-breaking Libtayo® (cemiplimab) Pivotal Data in Advanced Non-small Cell Lung Cancer and Basal Cell Carcinoma to Be Presented at ESMO

Regeneron Pharmaceuticals, Inc. and Sanofi announced the presentation of new, positive data for the PD-1 inhibitor Libtayo® at the European Society for Medical Oncology Virtual Congress 2020 from September 19-21.

September 3, 2020
·
18 min read
BioMidwest

Bio-Techne To Present At The 2020 Wells Fargo Virtual Healthcare Conference

Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 2020 Wells Fargo Virtual Healthcare Conference on Wednesday, September 9, 2020 at 11:20 a.m. EDT.

September 3, 2020
·
2 min read
BioMidwest

Avanos Medical, Inc. Announces Publication of Clinical Trial Demonstrating Superiority of COOLIEF* over Hyaluronic Acid Injections for the Management of Chronic Knee Pain

Avanos Medical, Inc. announced the publication of a large, randomized, multicentered clinical trial comparing the safety and efficacy of COOLIEF* Cooled Radiofrequency ablation to hyaluronic acid injection for the management of chronic knee pain caused by osteoarthritis.

September 3, 2020
·
3 min read
BioMidwest

Zimmer Biomet to Present at Wells Fargo 2020 Virtual Healthcare Conference

Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced that President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, September 9, 2020 at 11:20 a.m. Eastern Time.

September 3, 2020
·
1 min read
Compugen to Present at Upcoming September 2020 Investor Conferences

Compugen Ltd., a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, announced that management will present at the following upcoming virtual investor conferences

September 3, 2020
·
1 min read
Policy

Valeo Pharma Receives Hesperco™ Natural Product License Approval From Health Canada

Valeo Pharma Inc., a Canadian specialty pharmaceutical company, announced that it has received a Natural Product Licence approval from Health Canada authorizing the sale of its bioflavonoid formulation, HespercoTM, in Canada.

September 3, 2020
·
2 min read
Drug Development

Akebia Therapeutics Announces Top-Line Results from its PRO2TECT Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients Not on Dialysis

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, announces top-line results from PRO2TECT, the second of its two global Phase 3 cardiovascular outcomes programs.

September 3, 2020
·
15 min read